Please enable JavaScript to continue using this application.

Compare $GLSI vs $STRO | Chartloom

Compare

$GLSI vs $STRO

Greenwich Lifesciences Inc · Sutro Biopharma Inc

GLSI

Greenwich Lifesciences Inc

STRO

Sutro Biopharma Inc

Compare $GLSI vs $STRO

Comparing Greenwich Lifesciences Inc and Sutro Biopharma Inc

GLSIGreenwich Lifesciences Inc

STROSutro Biopharma Inc

GLSIGreenwich Lifesciences Inc

Market cap

$243M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-15.1%

52W performance

44.4%

FCF yield

-5.1%

STROSutro Biopharma Inc

Market cap

$236M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

6.01x

Rev growth (TTM)

-56.3%

YTD performance

30.2%

52W performance

67.2%

FCF yield

-61.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

GLSI

STRO

Detailed metrics comparison

GLSI

Greenwich Lifesciences Inc

STRO

Sutro Biopharma Inc

Market Cap

GLSI$243M

STRO$236M

Enterprise Value

GLSI$234M

STRO$421M

Price

GLSI$16.53

STRO$14.27

P/E Ratio

GLSIN/A

STRON/A

P/S Ratio

GLSI0.00x

STRO5.17x

EV/Sales

GLSI0.00x

STRO9.22x

EV/EBITDA

GLSI0.00x

STRO0.00x

P/B Ratio

GLSI79.96x

STRO5.78x

P/FCF Ratio

GLSIN/A

STRON/A

EV/FCF

GLSI-18.72x

STRO-2.89x

PEG Ratio

GLSIN/A

STRON/A

Forward P/E (NTM)

GLSIN/A

STRON/A

Forward P/S (NTM)

GLSIN/A

STRO6.01x

Revenue (TTM)

GLSI$0

STRO$46M

Revenue Growth (YoY)

GLSIN/A

STRO-56.3%

Forward Rev Growth

GLSI0.0%

STRO-19.2%

Gross Margin (TTM)

GLSI0.0%

STRO0.0%

Operating Margin (TTM)

GLSI0.0%

STRO0.0%

EBITDA Margin (TTM)

GLSI0.0%

STRO-275.3%

Net Margin (TTM)

GLSI0.0%

STRO-395.2%

FCF Margin (TTM)

GLSIN/A

STRO-318.6%

Net Income (TTM)

GLSI$-22M

STRO$-181M

FCF (TTM)

GLSI$-12M

STRO$-146M

EPS (TTM)

GLSI-$1.48

STRO-$10.90

ROE (TTM)

GLSI-79376.0%

STRO-22384.0%

ROA (TTM)

GLSI-29531.0%

STRO-8812.0%

ROIC (TTM)

GLSI-79376.0%

STRO-22384.0%

Cash

GLSI$9M

STRO$54M

Debt

GLSI$0

STRO$239M

Net Cash/Debt

GLSI$9M

STRO$-185M

Current Ratio (TTM)

GLSI1.54x

STRO3.32x

Quick Ratio (TTM)

GLSI1.54x

STRO3.22x

Debt/Equity (TTM)

GLSI0.00x

STRO4.05x

Debt/Assets (TTM)

GLSI0.0%

STRO0.0%

Interest Coverage (TTM)

GLSIN/A

STRON/A

Net Debt/EBITDA (TTM)

GLSI0.00x

STRO0.00x

Beta

GLSI1.54

STRO1.47

52W Performance

GLSI44.4%

STRO67.2%

YTD Performance

GLSI-15.1%

STRO30.2%

% from 52W High

GLSI-51.5%

STRO-67.5%

% from 52W Low

GLSI112.5%

STRO99.6%

Asset Turnover (TTM)

GLSI0.00x

STRO0.22x

FCF Yield (TTM)

GLSI-5.1%

STRO-61.6%

Earnings Yield (TTM)

GLSI-8.9%

STRO-76.4%

Dividend Yield (TTM)

GLSIN/A

STRON/A

Rule of 40

GLSI0.0

STRO-374.9

EV/GP/RG

GLSIN/A

STRON/A

Ticker research

View GLSI research View STRO research

Metric	GLSI Greenwich Lifesciences Inc	STRO Sutro Biopharma Inc
Market & Valuation
Market Cap	$243M	$236M
Enterprise Value	$234M	$421M
Price	$16.53	$14.27
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	5.17x
EV/Sales	0.00x	9.22x
EV/EBITDA	0.00x	0.00x
P/B Ratio	79.96x	5.78x
P/FCF Ratio	N/A	N/A
EV/FCF	-18.72x	-2.89x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	6.01x
Revenue & Growth
Revenue (TTM)	$0	$46M
Revenue Growth (YoY)	N/A	-56.3%
Forward Rev Growth	0.0%	-19.2%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-275.3%
Net Margin (TTM)	0.0%	-395.2%
FCF Margin (TTM)	N/A	-318.6%
Net Income (TTM)	$-22M	$-181M
FCF (TTM)	$-12M	$-146M
EPS (TTM)	-$1.48	-$10.90
ROE (TTM)	-79376.0%	-22384.0%
ROA (TTM)	-29531.0%	-8812.0%
ROIC (TTM)	-79376.0%	-22384.0%
Financial Health
Cash	$9M	$54M
Debt	$0	$239M
Net Cash/Debt	$9M	$-185M
Current Ratio (TTM)	1.54x	3.32x
Quick Ratio (TTM)	1.54x	3.22x
Debt/Equity (TTM)	0.00x	4.05x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.54	1.47
52W Performance	44.4%	67.2%
YTD Performance	-15.1%	30.2%
% from 52W High	-51.5%	-67.5%
% from 52W Low	112.5%	99.6%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.22x
FCF Yield (TTM)	-5.1%	-61.6%
Earnings Yield (TTM)	-8.9%	-76.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-374.9
EV/GP/RG	N/A	N/A
Ticker research	View GLSI research	View STRO research

Valuation

P/S Ratio

GLSI

0.00x

STRO

5.17x

EV/FCF

GLSI

-18.72x

STRO

-2.89x

Growth & revenue

Revenue Growth TTM

STRO

-56.3%

Forward Revenue Growth

GLSI

0.0%

STRO

-19.2%

Profitability & performance

Gross Margin

GLSI

0.0%

STRO

0.0%

ROE

STRO

-22384.0%

GLSI

-79376.0%

FCF Yield %

GLSI

-5.1%

STRO

-61.6%

52-Week Performance

STRO

67.2%

GLSI

44.4%

Detailed metrics comparison

GLSI

Greenwich Lifesciences Inc

STRO

Sutro Biopharma Inc

Market Cap

GLSI$243M

STRO$236M

Enterprise Value

GLSI$234M

STRO$421M

Price

GLSI$16.53

STRO$14.27

P/E Ratio

GLSIN/A

STRON/A

P/S Ratio

GLSI0.00x

STRO5.17x

EV/Sales

GLSI0.00x

STRO9.22x

EV/EBITDA

GLSI0.00x

STRO0.00x

P/B Ratio

GLSI79.96x

STRO5.78x

P/FCF Ratio

GLSIN/A

STRON/A

EV/FCF

GLSI-18.72x

STRO-2.89x

PEG Ratio

GLSIN/A

STRON/A

Forward P/E (NTM)

GLSIN/A

STRON/A

Forward P/S (NTM)

GLSIN/A

STRO6.01x

Revenue (TTM)

GLSI$0

STRO$46M

Revenue Growth (YoY)

GLSIN/A

STRO-56.3%

Forward Rev Growth

GLSI0.0%

STRO-19.2%

Gross Margin (TTM)

GLSI0.0%

STRO0.0%

Operating Margin (TTM)

GLSI0.0%

STRO0.0%

EBITDA Margin (TTM)

GLSI0.0%

STRO-275.3%

Net Margin (TTM)

GLSI0.0%

STRO-395.2%

FCF Margin (TTM)

GLSIN/A

STRO-318.6%

Net Income (TTM)

GLSI$-22M

STRO$-181M

FCF (TTM)

GLSI$-12M

STRO$-146M

EPS (TTM)

GLSI-$1.48

STRO-$10.90

ROE (TTM)

GLSI-79376.0%

STRO-22384.0%

ROA (TTM)

GLSI-29531.0%

STRO-8812.0%

ROIC (TTM)

GLSI-79376.0%

STRO-22384.0%

Cash

GLSI$9M

STRO$54M

Debt

GLSI$0

STRO$239M

Net Cash/Debt

GLSI$9M

STRO$-185M

Current Ratio (TTM)

GLSI1.54x

STRO3.32x

Quick Ratio (TTM)

GLSI1.54x

STRO3.22x

Debt/Equity (TTM)

GLSI0.00x

STRO4.05x

Debt/Assets (TTM)

GLSI0.0%

STRO0.0%

Interest Coverage (TTM)

GLSIN/A

STRON/A

Net Debt/EBITDA (TTM)

GLSI0.00x

STRO0.00x

Beta

GLSI1.54

STRO1.47

52W Performance

GLSI44.4%

STRO67.2%

YTD Performance

GLSI-15.1%

STRO30.2%

% from 52W High

GLSI-51.5%

STRO-67.5%

% from 52W Low

GLSI112.5%

STRO99.6%

Asset Turnover (TTM)

GLSI0.00x

STRO0.22x

FCF Yield (TTM)

GLSI-5.1%

STRO-61.6%

Earnings Yield (TTM)

GLSI-8.9%

STRO-76.4%

Dividend Yield (TTM)

GLSIN/A

STRON/A

Rule of 40

GLSI0.0

STRO-374.9

EV/GP/RG

GLSIN/A

STRON/A

Ticker research

View GLSI research View STRO research

Metric	GLSI Greenwich Lifesciences Inc	STRO Sutro Biopharma Inc
Market & Valuation
Market Cap	$243M	$236M
Enterprise Value	$234M	$421M
Price	$16.53	$14.27
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	5.17x
EV/Sales	0.00x	9.22x
EV/EBITDA	0.00x	0.00x
P/B Ratio	79.96x	5.78x
P/FCF Ratio	N/A	N/A
EV/FCF	-18.72x	-2.89x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	6.01x
Revenue & Growth
Revenue (TTM)	$0	$46M
Revenue Growth (YoY)	N/A	-56.3%
Forward Rev Growth	0.0%	-19.2%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-275.3%
Net Margin (TTM)	0.0%	-395.2%
FCF Margin (TTM)	N/A	-318.6%
Net Income (TTM)	$-22M	$-181M
FCF (TTM)	$-12M	$-146M
EPS (TTM)	-$1.48	-$10.90
ROE (TTM)	-79376.0%	-22384.0%
ROA (TTM)	-29531.0%	-8812.0%
ROIC (TTM)	-79376.0%	-22384.0%
Financial Health
Cash	$9M	$54M
Debt	$0	$239M
Net Cash/Debt	$9M	$-185M
Current Ratio (TTM)	1.54x	3.32x
Quick Ratio (TTM)	1.54x	3.22x
Debt/Equity (TTM)	0.00x	4.05x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.54	1.47
52W Performance	44.4%	67.2%
YTD Performance	-15.1%	30.2%
% from 52W High	-51.5%	-67.5%
% from 52W Low	112.5%	99.6%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.22x
FCF Yield (TTM)	-5.1%	-61.6%
Earnings Yield (TTM)	-8.9%	-76.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-374.9
EV/GP/RG	N/A	N/A
Ticker research	View GLSI research	View STRO research